NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
Want to monitor GERN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor GERNwe are a biopharmaceutical company developing first-in-class therapies for cancer.